Omakase has participated in a expert panel on "EU Joint HTA of Orphan Drugs and [...]
Omakase Consulting, in line with its strategy and thrive for continuous growth a [...]
We are very pleased to share a new publication of which OMAKASE is a co-author t [...]
Today, we are pleased to share with you the publication of our latest work using [...]
Alicia Gil, CEO Omakase Consulting attended yesterday a session held in the Span [...]
The Spanish Ministry of Health has updated the information system BIFIMED, an in [...]
We have opened new offices in #Madrid. We inaugurate this new space with great e [...]
The Spanish agency of medicines, the AEMPS, has been recognised for their work t [...]
We are glad to inform you about the Revalmed Coordination Group regular meeting [...]
We are proud to announce the release of the annual update of the "Report on Orph [...]
